Does anyone know the expected results date for the phase 3 clinical trials? Or any of the expected key announcement dates over the next 12 months?
OPT website says clinical trials have been initiated (extract below) but I cant find any other information.
"Opthea has completed a Phase 2b clinical trial investigating OPT-302 in wet AMD patients, and has completed a Phase 1b/2a clinical trial in patients with DME. Opthea is planning to initiate two pivotal Phase 3 clinical trials for the treatment of wet AMD in the first half of 2021."
Key Phase 3 Clinical Trial Dates
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $376.5M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 35.0¢ | 33.5¢ | $986.8K | 2.875M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55705 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 29727 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |